Ileocecal tuberculosis (ITB) is the commonest form of abdominal tuberculosis and a routine call in high-burden regions. The real diagnostic challenge is not detecting bowel disease but separating it from Crohn’s disease, which it mimics clinically, endoscopically and radiologically. This page covers the CT and MRI features, the classic barium signs, a point-by-point comparison with Crohn’s disease using the most discriminating imaging features, and where an empirical anti-tubercular therapy (ATT) trial fits in.
Quiz
The least likely feature of abdominal tuberculosis is?
- A. Necrotic lymph nodes
- B. Mesenteric vascular engorgement
- C. Ascites
- D. Stricture
Click here for the answer
Answer: B. Mesenteric vascular engorgement (the comb sign) is characteristic of Crohn’s disease, the prime differential of intestinal TB, and is usually absent in tuberculosis.
Pathophysiology
Intestinal TB can involve any part of the gastrointestinal tract. The terminal ileum and ileocaecal valve are the most commonly involved (about 90% of cases) because of abundant lymphoid tissue, physiological stasis, and increased rate of absorption in the region.
Modes of infection of intestinal TB include:
- Ingestion of infected food, milk, or sputum
- Hematogenous spread from distant focus, for eg: lung
- Contiguous spread from infected adjacent foci- eg: renal, fallopian tubes or adnexa, psoas abscess, secondary to Pott’s spine
- Through lymphatic channel
Inflammation starts in the submucosal lymphoid tissue resulting in wall thickening due to the formation of epithelioid tubercles and lymphoid hyperplasia. After 2-4 weeks, caseous necrosis of the tubercles leads to ulceration of the overlying mucosa. Further extension occurs into the deeper layers of the bowel wall and to regional lymph nodes. Fibrosis and scarring occur in the advanced stage of the disease.
Key Imaging Features
CT enterography is the primary modality. The features below can be scanned quickly at the workstation.
| Modality | Key findings in ileocecal TB |
|---|---|
| CT / MRI | Circumferential, often asymmetric thickening of the ileocaecal valve and medial cecal wall (cone-shaped cecum) with exophytic engulfment of the terminal ileum; mucosal or mural enhancement in active disease; progressive cecal scarring and short-segment strictures. |
| Lymph nodes | Mesenteric, omental and peripancreatic nodes >1 cm with central low-attenuation (caseous) necrosis and peripheral rim enhancement; calcified nodes in healed disease. This is the most specific sign of TB. |
| Peritoneum | Smooth omental and peritoneal thickening with high-density (“wet”) ascites in disseminated abdominal TB. |
| Ultrasound | Cecal/terminal-ileal wall thickening, mural colour flow (treatment monitoring), necrotic nodes, ascites, “pseudokidney sign” of the pulled-up ileocaecal region. |
| Radiograph | Abdomen: acute obstruction or pneumoperitoneum. Chest: coexistent active or healed pulmonary TB. |
Classic barium signs
Barium meal follow-through and enteroclysis are largely historical but remain high-yield for examinations. Enteroclysis has higher sensitivity for mucosal abnormality and mild strictures, but provides no extraluminal information.
| Sign | Finding |
|---|---|
| Stierlin’s sign | Rapid emptying of the irritable, narrowed cecum with barium retained in the terminal ileum and ascending colon. |
| Fleischner sign (inverted umbrella) | Wide, patulous, gaping, incompetent ileocaecal valve with narrowing of the terminal ileum. |
| Goose-neck deformity | Contracted, cicatrized, pulled-up cecum with straightening of the terminal ileum. |
| String sign | Persistently narrowed segment of bowel due to inflammation or stricture. |
| Chicken intestine | Hypersegmentation of the barium column. |
Imaging Recommendation
CT enterography is the investigation of choice because it best depicts both mural and extraluminal findings (necrotic nodes, peritoneum, coexistent solid-organ disease). MR enterography is a radiation-free alternative, useful in young patients and for follow-up.
Ileocecal Tuberculosis vs Crohn’s Disease
Separating ITB from Crohn’s disease (CD) is the central diagnostic dilemma, and getting it wrong is dangerous: steroids or biologics given for presumed CD can disseminate unrecognised TB, while prolonged ATT delays CD treatment. No single feature is perfect, so imaging findings are weighed together with endoscopy, histology and microbiology.
| Feature | Ileocecal tuberculosis | Crohn’s disease |
|---|---|---|
| Segment length | Short-segment, focal ileocaecal disease | Long-segment involvement (more than 3 cm) |
| Distribution | Cecum and ileocaecal valve, often asymmetric | Skip lesions along the mesenteric border, distal ileum |
| Ileocaecal valve | Thickened, fixed, gaping and incompetent (patulous) | Narrowed and stenosed |
| Lymph nodes | Necrotic (central low density) or calcified nodes | Reactive, small, homogeneous, non-necrotic |
| Comb sign / vasa recta | Usually absent | Present (engorged mesenteric vasa recta) |
| Fibrofatty (creeping fat) proliferation | Absent | Present |
| Mural stratification (target sign) | Less common | Common |
| Ascites / peritoneal thickening | May be present | Absent |
| Complications | Strictures, perforation, obstruction | Fistulae, perianal disease, abscess |
| Extraintestinal clue | Coexistent pulmonary or nodal TB | Uveitis, arthritis, skin lesions |
A systematic review and meta-analysis of CT features (Kedia et al., Intest Res 2017) quantified how discriminating these signs are:
| Sign | Points to | Specificity |
|---|---|---|
| Necrotic lymph node | Tuberculosis | ~100% (diagnostic odds ratio 30.2) |
| Comb sign | Crohn’s disease | ~81% (diagnostic odds ratio 21.5) |
| Skip lesions | Crohn’s disease | ~74% (diagnostic odds ratio 16.5) |
| Long-segment involvement | Crohn’s disease | High (almost exclusive to CD) |
| Left-sided colonic involvement | Crohn’s disease | High |
The empirical ATT trial. When clinical, endoscopic and imaging findings remain equivocal and TB cannot be excluded, guidelines support a therapeutic trial of anti-tubercular therapy for 8 to 12 weeks. Response is assessed at 2 to 3 months: symptomatic and mucosal (endoscopic) healing supports ITB, and ATT is continued to complete 6 months. Persistent or worsening disease despite an adequate trial points to Crohn’s disease and should prompt repeat endoscopic or radiological evaluation. Symptom improvement alone is unreliable, because many CD patients improve symptomatically on ATT without mucosal healing.
Top 3 Differential Diagnoses
- Crohn’s disease: Long-segment, mesenteric-border wall thickening with skip lesions, mural stratification, comb sign and fibrofatty proliferation. No ascites or necrotic nodes. Longer symptom duration with extraintestinal manifestations.
- Primary cecal malignancy: Elderly population, asymmetric nodular cecal wall thickening with non-necrotic lymph nodes and distant metastases. Final diagnosis by endoscopic biopsy.
- Small bowel lymphoma: Ileum is the primary site; aneurysmal dilatation of bowel loops, bulky non-necrotic lymphadenopathy and hepatosplenomegaly.
Clinical Features
- Age/sex predilection: equal sex predisposition, young adults.
- Risk factors: malnutrition, alcoholism, diabetes, chronic renal failure, HIV/AIDS, immunosuppression.
- Symptoms: abdominal pain, anorexia, fever, change in bowel habits, nausea and vomiting, weight loss, abdominal distension.
- Complications: upper and lower GI bleeding, fistula and stricture formation, bowel obstruction, intussusception, perforation, and malabsorption.
Classification System
Ileocecal tuberculosis is classically divided into three morphological types, ulcerative being the most common:
| Type | Features |
|---|---|
| Ulcerative (most common) | Superficial, transverse ulcers that heal by fibrosis, leading to strictures. |
| Hypertrophic | Mass-like mural thickening with scarring and fibrosis; can mimic malignancy. |
| Ulcerohypertrophic | Mixed pattern with both ulceration and hypertrophy. |
Etymology and Synonyms
Tuberculosis comes from the Latin word “tuberculum,” meaning a “small swelling.” Robert Koch identified and described the bacillus causing tuberculosis and was awarded the Nobel Prize for this discovery. Synonyms in use include intestinal tuberculosis, gastrointestinal tuberculosis, and ileocaecal TB.
Treatment
The mainstay is medical therapy with standard anti-tubercular drugs, isoniazid, rifampicin, pyrazinamide and ethambutol, tailored to drug-resistance patterns; a standard course runs 6 months. Surgery is reserved for complications:
- Bypass of involved bowel segments (entero-enterostomy, ileo-colostomy).
- Radical resection of involved segments (right hemicolectomy).
- Conservative surgery (strictureplasty) for strictures causing more than 50% luminal narrowing.
Frequently Asked Questions
How do you differentiate ileocecal tuberculosis from Crohn’s disease on CT?
Favour tuberculosis when there are necrotic or calcified lymph nodes, short-segment ileocaecal disease, a gaping incompetent ileocaecal valve, ascites and coexistent pulmonary TB. Favour Crohn’s disease with long-segment involvement, skip lesions, the comb sign (engorged vasa recta) and fibrofatty proliferation. Necrotic lymph nodes are the single most specific sign of TB, while the comb sign and skip lesions are the most specific for Crohn’s disease.
What is the most specific imaging sign of intestinal tuberculosis?
Necrotic (central low-attenuation) mesenteric lymph nodes with peripheral rim enhancement. In meta-analysis this sign has close to 100% specificity for TB, although its sensitivity is low, so its absence does not exclude the disease.
What is the investigation of choice for ileocecal tuberculosis?
CT enterography, because it demonstrates both the mural changes and extraluminal findings such as necrotic nodes, peritoneal disease and ascites. MR enterography is a radiation-free alternative, and colonoscopy with biopsy provides tissue for confirmation.
Which part of the bowel is most commonly involved in intestinal TB?
The ileocaecal region, terminal ileum and ileocaecal valve, is involved in about 90% of cases, owing to its abundant lymphoid tissue and relative physiological stasis.
What is an empirical anti-tubercular therapy trial?
When the diagnosis stays uncertain between TB and Crohn’s disease, a therapeutic trial of anti-tubercular therapy is given for 8 to 12 weeks and the response reassessed at 2 to 3 months. Symptomatic plus mucosal (endoscopic) healing supports tuberculosis; persistent active disease points to Crohn’s disease.
References
- Debi U, Ravisankar V, Prasad KK, Sinha SK, Sharma AK. Abdominal tuberculosis of the gastrointestinal tract: revisited. World J Gastroenterol. 2014;20(40):14831-14840. PMID: 25356043.
- Sharma R, Madhusudhan KS, Ahuja V. Intestinal tuberculosis versus Crohn’s disease: clinical and radiological recommendations. Indian J Radiol Imaging. 2016;26(2):161-172. PMID: 27857458.
- Kedia S, Sharma R, Nagi B, et al. Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn’s disease: a systematic review with meta-analysis. Intest Res. 2017;15(2):149-159. PMID: 28522943.
- Pratap Mouli V, Munot K, Ananthakrishnan A, et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn’s disease. Aliment Pharmacol Ther. 2017;45(1):27-36. PMID: 27813111.
- Kedia S, Das P, Madhusudhan KS, et al. Differentiating Crohn’s disease from intestinal tuberculosis. World J Gastroenterol. 2019;25(4):418-432. PMID: 30700939.
Co-Authors: Dr. Mansi Sarmalkar, Dr. Disha Lokhandwala.
Improve Content And Help Your Colleagues!
Found an error in the post? Please let us know using our contact page and we will update it with due credits!
If you wish to contribute radiological images for this case (or any other article on the website), you can submit them here and you will be duly credited: Submit radiology case